Affix Labs Raises €1 Million to Advance Insect Repellent Technology
Affix Labs, based in Nijmegen, Netherlands, has successfully raised €1 million in an undisclosed funding round. The company specializes in developing patented, water-based insect repellent technology that offers long-lasting, non-killing solutions for B2B partners globally. Their products are compliant with the Biocidal Products Regulation (BPR), ensuring they meet rigorous safety and environmental standards.
Investment Details
The funding round was led by VP Capital and Oost NL. While specific details about other investors were not disclosed, the involvement of these leading investment firms highlights significant interest in Affix Labs' innovative approach to insect repellent solutions.
Strategic Use of Funds
Though specific plans for the use of the newly acquired funds have not been detailed, it is likely that Affix Labs will focus on enhancing their product offerings and expanding their market reach. Given the company's B2B focus, they may also aim to strengthen partnerships and distribution channels to deliver their technology to a wider audience.
A Growing Interest in Sustainable Solutions
Affix Labs' water-based technology aligns with a growing demand for sustainable and environmentally friendly products. Their non-killing approach to insect repellents meets the needs of businesses seeking effective yet eco-conscious solutions.
Conclusion
With the backing of VP Capital and Oost NL, Affix Labs is well-positioned to further develop its innovative technology and expand its presence in the global market. As the company continues to grow, it will be interesting to see how their products impact the insect repellent industry and contribute to sustainable practices worldwide.